Abstract
The heparosan polysaccharide serves as the starting carbon backbone for the chemoenzymatic synthesis of heparin, a widely used clinical anticoagulant drug. The previous quantification methods for heparosan rely on time-consuming purification or expensive instruments not readily available for many labs. Here, a chemoenzymatic approach is developed to monitor the production of heparosan in rich medium without purification. After removing the interfering small molecules by ultrafiltration, heparosan was decomposed into oligosaccharides using heparin lyase III. The oligosaccharides were separated from large molecules by ultrafiltration and quantitatively determined by the anthrone-sulfuric acid assay using a spectrophotometer. Based on the different substrate specificity of heparin lyases, the study showed that the concentration of heparosan and heparin in a mixture was discriminatively determined by the two-step chemoenzymatic assay. Furthermore, the anthrone-sulfuric acid assay was observed to be more reliable than the phenol-sulfuric acid assay under these conditions. Besides heparosan and heparin, the chemoenzymatic assay may be adapted to quantify other types of polysaccharides if the specific lyases were available.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
An C, Zhao L, Wei Z, Zhou X (2017) Chemoenzymatic synthesis of 3′-phosphoadenosine-5′-phosphosulfate coupling with an ATP regeneration system. Appl Microbiol Biotechnol 101(20):7535–7544. https://doi.org/10.1007/s00253-017-8511-2
Bao F, Yan H, Sun H, Yang P, Liu G, Zhou X (2015) Hydrolysis of by-product adenosine diphosphate from 3′-phosphoadenosine-5′-phosphosulfate preparation using Nudix hydrolase NudJ. Appl Microbiol Biotechnol 99(24):10771–10778. https://doi.org/10.1007/s00253-015-6911-8
Bhaskar U, Li G, Fu L, Onishi A, Suflita M, Dordick JS, Linhardt RJ (2015) Combinatorial one-pot chemoenzymatic synthesis of heparin. Carbohydr Polym 122(0):399–407. https://doi.org/10.1016/j.carbpol.2014.10.054
Bitter T, Muir HM (1962) A modified uronic acid carbazole reaction. Anal Biochem 4(4):330–334. https://doi.org/10.1016/0003-2697(62)90095-7
Brummer Y, Cui SW (2005) Understanding carbohydrate analysis. In: Cui SW (ed) Food carbohydrates: chemistry, physical properties and applications, 1st edn. CRC Press, Boca Raton, pp 67–104
Chen J, Jones CL, Liu J (2007) Using an enzymatic combinatorial approach to identify anticoagulant heparan sulfate structures. Chem Biol 14(9):986–993. https://doi.org/10.1016/j.chembiol.2007.07.015
Cress BF, Greene ZR, Linhardt RJ, Koffas MAG (2013a) Draft genome sequence of Escherichia coli strain ATCC 23506 (serovar O10:K5:H4). Genome Announc 1(2):e00049–e00013. https://doi.org/10.1128/genomeA.00049-13
Cress BF, Linhardt RJ, Koffas MAG (2013b) Draft genome sequence of Escherichia coli strain Nissle 1917 (serovar O6:K5:H1). Genome Announc 1(2):e0004713. https://doi.org/10.1128/genomeA.00047-13
Cress BF, Toparlak OD, Guleria S, Lebovich M, Stieglitz JT, Englaender JA, Jones JA, Linhardt RJ, Koffas MA (2015) CRISPathBrick: modular combinatorial assembly of type II-A CRISPR arrays for dCas9-mediated multiplex transcriptional repression in E. coli. ACS Synth Biol 4(9):987–1000. https://doi.org/10.1021/acssynbio.5b00012
Cress BF, Bhaskar U, Vaidyanathan D, Williams A, Cai C, Liu X, Fu L, V MC, Zhang F, Mousa SA, Dordick JS, Koffas MAG, Linhardt RJ (2019) Heavy heparin: a stable isotope-enriched, chemoenzymatically-synthesized, poly-component drug. Angew Chem Int Ed Eng 58(18):5962–5966. https://doi.org/10.1002/anie.201900768
DeAngelis PL, White CL (2002) Identification and molecular cloning of a heparosan synthase from Pasteurella multocida type D. J Biol Chem 277(9):7209–7213. https://doi.org/10.1074/jbc.M112130200
Desai UR, Wang HM, Linhardt RJ (1993) Substrate specificity of the heparin lyases from Flavobacterium heparinum. Arch Biochem Biophys 306(2):461–468. https://doi.org/10.1006/abbi.1993.1538
Guerrini M, Beccati D, Shriver Z, Naggi A, Viswanathan K, Bisio A, Capila I, Lansing JC, Guglieri S, Fraser B, Al-Hakim A, Gunay NS, Zhang Z, Robinson L, Buhse L, Nasr M, Woodcock J, Langer R, Venkataraman G, Linhardt RJ, Casu B, Torri G, Sasisekharan R (2008) Oversulfated chondroitin sulfate is a contaminant in heparin associated with adverse clinical events. Nat Biotechnol 26(6):669–675. https://doi.org/10.1038/nbt1407
Hashimoto W, Maruyama Y, Nakamichi Y, Mikami B, Murata K (2014) Crystal structure of Pedobacter heparinus heparin lyase Hep III with the active site in a deep cleft. Biochemistry (Mosc) 53(4):777–786. https://doi.org/10.1021/bi4012463
He W, Fu L, Li G, Andrew Jones J, Linhardt RJ, Koffas M (2015) Production of chondroitin in metabolically engineered E. coli. Metab Eng 27:92–100. https://doi.org/10.1016/j.ymben.2014.11.003
Holley MM, Zhang Y, Lehrmann E, Wood WH, Becker KG, Kielian T (2012) Toll-like receptor 2 (TLR2)-TLR9 crosstalk dictates IL-12 family cytokine production in microglia. Glia 60(1):29–42. https://doi.org/10.1002/glia.21243
Kang Z, Zhou Z, Wang Y, Huang H, Du G, Chen J (2018) Bio-based strategies for producing glycosaminoglycans and their oligosaccharides. Trends Biotechnol 36(8):806–818. https://doi.org/10.1016/j.tibtech.2018.03.010
Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, Lansing JC, Sriranganathan N, Zhao G, Galcheva-Gargova Z, Al-Hakim A, Bailey GS, Fraser B, Roy S, Rogers-Cotrone T, Buhse L, Whary M, Fox J, Nasr M, Dal Pan GJ, Shriver Z, Langer RS, Venkataraman G, Austen KF, Woodcock J, Sasisekharan R (2008) Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 358(23):2457–2467. https://doi.org/10.1056/NEJMoa0803200
Liu J, Thorp SC (2002) Cell surface heparan sulfate and its roles in assisting viral infections. Med Res Rev 22(1):1–25. https://doi.org/10.1002/med.1026
Liu H, Zhang Z, Linhardt RJ (2009) Lessons learned from the contamination of heparin. Nat Prod Rep 26(3):313–321. https://doi.org/10.1039/b819896a
Ly M, Wang Z, Laremore TN, Zhang F, Zhong W, Pu D, Zagorevski DV, Dordick JS, Linhardt RJ (2011) Analysis of E. coli K5 capsular polysaccharide heparosan. Anal Bioanal Chem 399(2):737–745. https://doi.org/10.1007/s00216-010-3679-7
Volpi N (2004) Purification of the Escherichia coli K5 capsular polysaccharide and use of high-performance capillary electrophoresis to qualitative and quantitative monitor the process. Electrophoresis 25(18-19):3307–3312. https://doi.org/10.1002/elps.200305856
Wang Z, Ly M, Zhang F, Zhong W, Suen A, Hickey AM, Dordick JS, Linhardt RJ (2010a) E. coli K5 fermentation and the preparation of heparosan, a bioengineered heparin precursor. Biotechnol Bioeng 107(6):964–973. https://doi.org/10.1002/bit.22898
Wang Z, Zhang Z, McCallum SA, Linhardt RJ (2010b) Nuclear magnetic resonance quantification for monitoring heparosan K5 capsular polysaccharide production. Anal Biochem 398(2):275–277. https://doi.org/10.1016/j.ab.2009.12.005
Wang Z, Dordick JS, Linhardt RJ (2011) Escherichia coli K5 heparosan fermentation and improvement by genetic engineering. Bioeng Bugs 2(1):63–67. https://doi.org/10.4161/bbug.2.1.14201
Xu D, Arnold K, Liu J (2018) Using structurally defined oligosaccharides to understand the interactions between proteins and heparan sulfate. Curr Opin Struct Biol 50:155–161. https://doi.org/10.1016/j.sbi.2018.04.003
Yan H, Bao F, Zhao L, Yu Y, Tang J, Zhou X (2015) Cyclic AMP (cAMP) receptor protein-cAMP complex regulates heparosan production in Escherichia coli strain Nissle 1917. Appl Environ Microbiol 81(22):7687–7696. https://doi.org/10.1128/aem.01814-15
Yang B, Chang Y, Weyers AM, Sterner E, Linhardt RJ (2012) Disaccharide analysis of glycosaminoglycan mixtures by ultra-high-performance liquid chromatography-mass spectrometry. J Chromatogr A 1225:91–98. https://doi.org/10.1016/j.chroma.2011.12.063
Zhang X, Wang F, Sheng J (2016) “Coding” and “Decoding”: hypothesis for the regulatory mechanism involved in heparan sulfate biosynthesis. Carbohydr Res 428:1–7. https://doi.org/10.1016/j.carres.2016.04.002
Zhou X, Chandarajoti K, Pham TQ, Liu R, Liu J (2011) Expression of heparan sulfate sulfotransferases in Kluyveromyces lactis and preparation of 3′-phosphoadenosine-5′-phosphosulfate. Glycobiology 21(6):771–780. https://doi.org/10.1093/glycob/cwr001
Funding
This work was financially supported by the National Natural Science Foundation of China (31670120).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical approval
This article does not contain any studies with human participants or animals performed by any of the authors.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Yu, Y., Ye, H., Wu, D. et al. Chemoenzymatic quantification for monitoring unpurified polysaccharide in rich medium. Appl Microbiol Biotechnol 103, 7635–7645 (2019). https://doi.org/10.1007/s00253-019-10042-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00253-019-10042-7